Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Aluminium overload after 5 years in skin biopsy following post-vaccination with subcutaneous pseudolymphoma.

Guillard O, Fauconneau B, Pineau A, Marrauld A, Bellocq JP, Chenard MP.

J Trace Elem Med Biol. 2012 Oct;26(4):291-3. doi: 10.1016/j.jtemb.2012.02.005.

PMID:
22425036
2.

[Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].

Gherardi RK.

Rev Neurol (Paris). 2003 Feb;159(2):162-4. Review. French.

PMID:
12660567
3.

[Vaccine adjuvants and macrophagic myofasciitis].

Siegrist CA.

Bull Acad Natl Med. 2003;187(8):1511-8; discussion 1519-21. Review. French.

PMID:
15146582
4.

Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.

Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.

Clin Rev Allergy Immunol. 2011 Oct;41(2):163-8. doi: 10.1007/s12016-010-8212-4. Review.

PMID:
20882368
5.

Aluminum inclusion macrophagic myofasciitis: a recently identified condition.

Gherardi RK, Authier FJ.

Immunol Allergy Clin North Am. 2003 Nov;23(4):699-712. Review.

PMID:
14753387
6.

[Subcutaneous nodules and sensitivity to aluminum in patients undergoing hyposensitivity immunotherapy].

García-Patos V, Alomar A, Lleonart R, Cistero A, Matias-Guiu X.

Med Cutan Ibero Lat Am. 1990;18(2):83-8. Review. Spanish.

PMID:
2145483
7.

Why aluminum phosphate is less toxic than aluminum hydroxide.

Berthon G, Daydé S.

J Am Coll Nutr. 1992 Jun;11(3):340-8. Review.

PMID:
1619187
8.

[Aluminum as an adjuvant in vaccines and post-vaccine reactions].

Fiejka M, Aleksandrowicz J.

Rocz Panstw Zakl Hig. 1993;44(1):73-80. Review. Polish.

PMID:
8235346
9.

[Vaccine adjuvants and macrophagic myofasciitis].

Siegrist CA.

Arch Pediatr. 2005 Jan;12(1):96-101. Review. French.

PMID:
15653065
10.

Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V.

J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1:1-269. Review. No abstract available. Erratum in: J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):147.

11.

If exposure to aluminium in antiperspirants presents health risks, its content should be reduced.

Pineau A, Fauconneau B, Sappino AP, Deloncle R, Guillard O.

J Trace Elem Med Biol. 2014 Apr;28(2):147-50. doi: 10.1016/j.jtemb.2013.12.002. Review.

PMID:
24418462
Items per page

Supplemental Content

Support Center